Cargando…
Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder
Indicated for treatment-resistant depression or major depression with suicidal ideation, esketamine (ESK) is self-administered under supervision at certified treatment centers. Our study was to determine if social determinants of health and distance were associated with ESK utilization. We conducted...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935983/ https://www.ncbi.nlm.nih.gov/pubmed/36800597 http://dx.doi.org/10.1097/MD.0000000000032895 |
_version_ | 1784890135610916864 |
---|---|
author | Liberman, Joshua Pesa, Jacqueline Rui, Pinyao Joshi, Kruti Harding, Lisa |
author_facet | Liberman, Joshua Pesa, Jacqueline Rui, Pinyao Joshi, Kruti Harding, Lisa |
author_sort | Liberman, Joshua |
collection | PubMed |
description | Indicated for treatment-resistant depression or major depression with suicidal ideation, esketamine (ESK) is self-administered under supervision at certified treatment centers. Our study was to determine if social determinants of health and distance were associated with ESK utilization. We conducted a retrospective cohort study among 308 US adults initiating ESK between October 11, 2019 and December 31, 2020 and 1540 propensity-score matched controls with treatment-resistant depression or major depression with suicidal ideation. Adjusting for demographics, prior health care utilization and comorbidities, social determinant variables and distance were regressed separately on each outcome: ESK initiation, failure to complete induction (8 treatments in 45 days), and discontinuation within 6 months. ESK initiation was associated with higher population density (odds ratio [OR]: 2.12), American Indian, Alaska Native, Native Hawaiian, Other Pacific Islander (OR: 3.19), and mental health (OR: 1.55) and primary care providers (OR: 1.55) per capita. Lower likelihood of ESK initiation was associated with living > 7.2 miles from a treatment center (OR: 0.75), living in rural areas (OR: 0.64), and percent non-Hispanic African American (OR: 0.58) and Hispanic (OR: 0.40). Health care providers should tailor patient engagement strategies to mitigate potential barriers to initiating and continuing appropriate treatment. Failing to complete induction was associated with substance use disorder and longer distance to treatment center was associated with discontinuation (hazard ratio: 1.48), as was percent Asian population (hazard ratio: 1.37). Prior psychiatric care and residence in counties with high rates of primary care providers per capita, unemployment, and high school graduation were associated with both higher likelihood of completing induction and lower likelihood of discontinuation. |
format | Online Article Text |
id | pubmed-9935983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-99359832023-02-18 Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder Liberman, Joshua Pesa, Jacqueline Rui, Pinyao Joshi, Kruti Harding, Lisa Medicine (Baltimore) 5000 Indicated for treatment-resistant depression or major depression with suicidal ideation, esketamine (ESK) is self-administered under supervision at certified treatment centers. Our study was to determine if social determinants of health and distance were associated with ESK utilization. We conducted a retrospective cohort study among 308 US adults initiating ESK between October 11, 2019 and December 31, 2020 and 1540 propensity-score matched controls with treatment-resistant depression or major depression with suicidal ideation. Adjusting for demographics, prior health care utilization and comorbidities, social determinant variables and distance were regressed separately on each outcome: ESK initiation, failure to complete induction (8 treatments in 45 days), and discontinuation within 6 months. ESK initiation was associated with higher population density (odds ratio [OR]: 2.12), American Indian, Alaska Native, Native Hawaiian, Other Pacific Islander (OR: 3.19), and mental health (OR: 1.55) and primary care providers (OR: 1.55) per capita. Lower likelihood of ESK initiation was associated with living > 7.2 miles from a treatment center (OR: 0.75), living in rural areas (OR: 0.64), and percent non-Hispanic African American (OR: 0.58) and Hispanic (OR: 0.40). Health care providers should tailor patient engagement strategies to mitigate potential barriers to initiating and continuing appropriate treatment. Failing to complete induction was associated with substance use disorder and longer distance to treatment center was associated with discontinuation (hazard ratio: 1.48), as was percent Asian population (hazard ratio: 1.37). Prior psychiatric care and residence in counties with high rates of primary care providers per capita, unemployment, and high school graduation were associated with both higher likelihood of completing induction and lower likelihood of discontinuation. Lippincott Williams & Wilkins 2023-02-17 /pmc/articles/PMC9935983/ /pubmed/36800597 http://dx.doi.org/10.1097/MD.0000000000032895 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | 5000 Liberman, Joshua Pesa, Jacqueline Rui, Pinyao Joshi, Kruti Harding, Lisa Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder |
title | Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder |
title_full | Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder |
title_fullStr | Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder |
title_full_unstemmed | Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder |
title_short | Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder |
title_sort | social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder |
topic | 5000 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935983/ https://www.ncbi.nlm.nih.gov/pubmed/36800597 http://dx.doi.org/10.1097/MD.0000000000032895 |
work_keys_str_mv | AT libermanjoshua socialdeterminantsanddistancefromcertifiedtreatmentcentersareassociatedwithinitiationofesketaminenasalsprayamongpatientswithchallengingtotreatmajordepressivedisorder AT pesajacqueline socialdeterminantsanddistancefromcertifiedtreatmentcentersareassociatedwithinitiationofesketaminenasalsprayamongpatientswithchallengingtotreatmajordepressivedisorder AT ruipinyao socialdeterminantsanddistancefromcertifiedtreatmentcentersareassociatedwithinitiationofesketaminenasalsprayamongpatientswithchallengingtotreatmajordepressivedisorder AT joshikruti socialdeterminantsanddistancefromcertifiedtreatmentcentersareassociatedwithinitiationofesketaminenasalsprayamongpatientswithchallengingtotreatmajordepressivedisorder AT hardinglisa socialdeterminantsanddistancefromcertifiedtreatmentcentersareassociatedwithinitiationofesketaminenasalsprayamongpatientswithchallengingtotreatmajordepressivedisorder |